SCHEMBL22074342

SCHEMBL22074342

Cc1cccc(OCC(=O)N(CC2CCCO2)c2ccccn2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 5/20 0.49
▸ THRB P10828 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ GAA P10253 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ LMNA P02545 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ TRPM8 Q7Z2W7 1/20 0.46
▸ TP53 P04637 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ HPGD P15428 2/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29780009 1.00 POLB (0.49) POLBTHRBKDM4ETDP1GAA
SCHEMBL22074357 0.89 GAA (0.60) POLBTHRBKDM4EGAASMN1; SMN2
SCHEMBL22074401 0.88 POLB (0.50) POLBKDM4EGAASMN1; SMN2LMNA
SCHEMBL29779994 0.88 POLB (0.50) POLBKDM4EGAASMN1; SMN2LMNA
SCHEMBL20773843 0.86 SMN1; SMN2 (0.50) THRBKDM4EGAASMN1; SMN2LMNA
SCHEMBL20777355 0.86 POLB (0.52) POLBGAASMN1; SMN2LMNAMEN1
SCHEMBL20772728 0.85 TRPM8 (0.59) POLBTHRBKDM4ETDP1GAA
SCHEMBL20773407 0.83 TRPM8 (0.52) THRBKDM4ESMN1; SMN2TRPM8TP53
SCHEMBL22074365 0.81 POLB (0.60) POLBGAAMEN1KMT2ATRPM8
SCHEMBL20773155 0.77 POLB (0.48) POLBGAASMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675809-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2023-09-27 — — EP disclosed
EP-3675809-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2023-09-27 — — EP disclosed
EP-3675809-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-07-08 — — EP disclosed
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-06-18 — — US disclosed
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190052-A1 USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS TRPM8, TRPM7, TRPM5 POLB 4708/4885THRB 754/4885KDM4E 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback